GenMark Diagnostics, Inc.·4

Jan 5, 8:20 PM ET

Cohen Matthew Robert 4

4 · GenMark Diagnostics, Inc. · Filed Jan 5, 2012

Insider Transaction Report

Form 4
Period: 2012-01-03
Cohen Matthew Robert
SVP, Gen Counsel & Secretary
Transactions
  • Award

    Common Stock

    2012-01-03$4.38/sh+26,856$117,62926,856 total
  • Award

    Stock Option (Right to Buy)

    2012-01-03+42,50042,500 total
    Exercise: $4.38Exp: 2022-01-03Common Stock (42,500 underlying)
Footnotes (2)
  • [F1]25% of the shares vest on November 7, 2012 and the remaining restricted stock vests in 12 quarterly installments thereafter.
  • [F2]25% of the option shares vest and become exercisable on November 7, 2012 and the remaining option shares vest and become exercisable in 36 monthly installments thereafter.

Documents

2 files